We are live on ! Find out more
CC

Commodore Capital Portfolio holdings

AUM $1.73B
1-Year Est. Return 298.96%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+298.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.73B
AUM Growth
+$226M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$49.8M
2
+$42.2M
3
+$37.5M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$36M
5
NUVL icon
Nuvalent
NUVL
+$28.9M

Top Sells

1
+$59.6M
2
+$53.1M
3
+$44.9M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$39.3M
5
ELVN icon
Enliven Therapeutics
ELVN
+$39.3M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
1
Relay Therapeutics
RLAY
$2.98B
$169M 9.79%
17,000,000
ALKS icon
2
Alkermes
ALKS
$7.37B
$149M 8.59%
4,200,000
+650,000
ELVN icon
3
Enliven Therapeutics
ELVN
$2.71B
$128M 7.43%
3,275,000
-1,417,809
COGT icon
4
Cogent Biosciences
COGT
$5.37B
$111M 6.43%
2,888,007
+691,162
SYRE icon
5
Spyre Therapeutics
SYRE
$6.63B
$96.5M 5.58%
1,912,380
-475,865
TYRA icon
6
Tyra Biosciences
TYRA
$1.52B
$94.8M 5.48%
2,475,000
-900,000
CLDX icon
7
Celldex Therapeutics
CLDX
$2.33B
$85.5M 4.95%
2,696,616
+131,616
NUVL icon
8
Nuvalent
NUVL
$9.76B
$85.4M 4.94%
833,600
+283,600
AMLX icon
9
Amylyx Pharmaceuticals
AMLX
$1.46B
$78.5M 4.54%
5,650,000
KYMR icon
10
Kymera Therapeutics
KYMR
$6.4B
$62.5M 3.61%
750,000
ANRO icon
11
Alto Neuroscience
ANRO
$698M
$61.2M 3.54%
2,723,196
+900,000
PHVS icon
12
Pharvaris
PHVS
$2.2B
$54.2M 3.14%
1,918,970
+29,525
ERAS icon
13
Erasca
ERAS
$4.14B
$51.4M 2.97%
+3,175,000
DMRA
14
Damora Therapeutics
DMRA
$1.25B
$50.2M 2.91%
+1,939,000
XENE icon
15
Xenon Pharmaceuticals
XENE
$4.96B
$48M 2.78%
825,000
-975,000
DFTX
16
Definium Therapeutics
DFTX
$2.53B
$37.8M 2.19%
2,000,000
LBRX
17
LB Pharmaceuticals
LBRX
$834M
$37M 2.14%
1,500,000
EYPT icon
18
EyePoint Inc
EYPT
$1.03B
$36.4M 2.11%
+2,825,000
NRIX icon
19
Nurix Therapeutics
NRIX
$1.63B
$35.3M 2.04%
2,275,000
CRVS icon
20
Corvus Pharmaceuticals
CRVS
$927M
$33M 1.91%
+2,258,735
ASMB icon
21
Assembly Biosciences
ASMB
$442M
$27.8M 1.61%
1,000,000
CATX icon
22
Perspective Therapeutics
CATX
$338M
$26.4M 1.53%
+6,336,782
SLNO
23
DELISTED
Soleno Therapeutics
SLNO
$21.8M 1.26%
652,432
-547,568
OCUL icon
24
Ocular Therapeutix
OCUL
$1.88B
$21.8M 1.26%
+2,575,000
IPSC icon
25
Century Therapeutics
IPSC
$386M
$19.7M 1.14%
+8,695,652
1
2